Search all trials

Find therapies in clinical trials near you – page 6

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Non-small cell lung cancer+5

Recruiting

Registered drugNo placebo

Study of cemiplimab treatment after surgery in patients with stage II-IIIA non-small cell lung cancer who have not received chemotherapy and have PD-L1 expression of 1% or higher

Registered drugNo placebo

Ireland

Participants:18–64 years · 65+ years
Substances:Cemiplimab

Contact Research Centre

Plasma cell myeloma

Recruiting

Registered drugNo placebo

Study comparing daratumumab, lenalidomide and dexamethasone followed by linvoseltamab versus continued initial treatment in newly diagnosed multiple myeloma patients

Registered drugNo placebo

Ireland

Participants:18–64 years · 65+ years
Substances:Daratumumab

Contact Research Centre

Squamous cell carcinoma of head and neck

Recruiting

Registered drug

Study of ficerafusp alfa and pembrolizumab as first treatment for patients with PD-L1-positive recurrent or metastatic head and neck cancer

Registered drug

Ireland

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Major depression

Recruiting

Investigational

Study of deupsilocin besilate (CYB003) in adults with major depressive disorder comparing two doses against placebo

Investigational

Ireland

Participants:18–64 years · 65+ years

Contact Research Centre

Idiopathic pulmonary fibrosis

Recruiting

Registered drug

Study of MTX-463 compared to placebo to assess its safety and effectiveness in adults with idiopathic pulmonary fibrosis

Registered drug

Ireland

Participants:18–64 years · 65+ years
Substances:Glucose Monohydrate

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drugNo placebo

Study comparing RMC-6236 and docetaxel in previously treated patients with advanced or metastatic non-small cell lung cancer who have RAS mutations

Registered drugNo placebo

Ireland

Participants:18–64 years · 65+ years
Substances:Docetaxel

Contact Research Centre

B-cell small lymphocytic lymphoma refractory+1

Recruiting

Registered drugNo placebo

Study of sonrotoclax plus obinutuzumab or rituximab compared to venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia

Registered drugNo placebo

Ireland

Participants:18–64 years · 65+ years
Substances:Obinutuzumab

Contact Research Centre

Major depression

Recruiting

InvestigationalNo placebo

Long-term safety and effectiveness study of CYB003 (deupsilocin besilate) with optional additional doses for people with Major Depressive Disorder

InvestigationalNo placebo

Ireland

Participants:18–64 years · 65+ years

Contact Research Centre

Phenylketonuria

Recruiting

Registered drugNo placebo

Study of Long-Term Neurocognitive Outcomes in Children with Phenylketonuria Treated with Sepiapterin

Registered drugNo placebo

Ireland

Participants:0–17 years
Substances:Sepiapterin

Contact Research Centre

Endometrial cancer

Recruiting

Registered drugNo placebo

Study of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Advanced or Recurrent Endometrial Cancer

Registered drugNo placebo

Ireland

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Study of Rilvegostomig or Pembrolizumab for First-line Treatment in Patients with PD-L1-high Metastatic Non-small Cell Lung Cancer

Recruiting

Registered drugNo placebo

Study of Rilvegostomig or Pembrolizumab for First-line Treatment in Patients with PD-L1-high Metastatic Non-small Cell Lung Cancer

Registered drugNo placebo

Ireland

Participants:18–64 years · 65+ years
Substances:Infliximab

Contact Research Centre

Study on the Safety and Immune Response of the MVA-BN Vaccine Booster for Monkeypox Prevention in Previously Vaccinated Patients

Recruiting

Registered drugNo placebo

Study on the Safety and Immune Response of the MVA-BN Vaccine Booster for Monkeypox Prevention in Previously Vaccinated Patients

Registered drugNo placebo

Ireland

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Modified Vaccinia Ankara – Bavarian Nordic Live Virus

Contact Research Centre

Find therapies in clinical trials near you – page 6

442 trials match your criteria

Non-small cell lung cancer+5

Study of cemiplimab treatment after surgery in patients with stage II-IIIA non-small cell lung cancer who have not received chemotherapy and have PD-L1 expression of 1% or higher

Plasma cell myeloma

Study comparing daratumumab, lenalidomide and dexamethasone followed by linvoseltamab versus continued initial treatment in newly diagnosed multiple myeloma patients

Squamous cell carcinoma of head and neck

Study of ficerafusp alfa and pembrolizumab as first treatment for patients with PD-L1-positive recurrent or metastatic head and neck cancer

Major depression

Study of deupsilocin besilate (CYB003) in adults with major depressive disorder comparing two doses against placebo

Idiopathic pulmonary fibrosis

Study of MTX-463 compared to placebo to assess its safety and effectiveness in adults with idiopathic pulmonary fibrosis

Non-small cell lung cancer

Study comparing RMC-6236 and docetaxel in previously treated patients with advanced or metastatic non-small cell lung cancer who have RAS mutations

B-cell small lymphocytic lymphoma refractory+1

Study of sonrotoclax plus obinutuzumab or rituximab compared to venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia

Major depression

Long-term safety and effectiveness study of CYB003 (deupsilocin besilate) with optional additional doses for people with Major Depressive Disorder

Phenylketonuria

Study of Long-Term Neurocognitive Outcomes in Children with Phenylketonuria Treated with Sepiapterin

Endometrial cancer

Study of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Advanced or Recurrent Endometrial Cancer

Study of Rilvegostomig or Pembrolizumab for First-line Treatment in Patients with PD-L1-high Metastatic Non-small Cell Lung Cancer

Study of Rilvegostomig or Pembrolizumab for First-line Treatment in Patients with PD-L1-high Metastatic Non-small Cell Lung Cancer

Study on the Safety and Immune Response of the MVA-BN Vaccine Booster for Monkeypox Prevention in Previously Vaccinated Patients

Study on the Safety and Immune Response of the MVA-BN Vaccine Booster for Monkeypox Prevention in Previously Vaccinated Patients

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.